Skip to content
Parakho

Solara Active Pharma Sciences Ltd

NSE SOLARABSE 541540solara.co.inInvestor relations

Q1 FY27, unaudited

Revenue
₹381.60 Cr
Profit after tax
₹16.99 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations381.60+19.57%1,368.98
Other income1.92+95.92%5.89
Total income383.52+19.80%1,374.87
Employee benefit expense56.05+4.49%219.20
Finance costs20.23−15.36%94.24
Depreciation & amortisation26.71+13.27%99.68
Total expenses366.53+18.39%1,376.22
Profit before tax16.99+61.35%-7.24
Tax expense0.00—0.00
Profit after tax16.99+61.35%-7.24
Total comprehensive income16.99+61.35%-3.97
Earnings per share
Earnings per share, basic₹3.67₹-1.64
Earnings per share, diluted₹3.67₹-1.64

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — unaudited, from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Solara Active Pharma Sciences reported Q1 FY27 revenue of INR384 crores, up 20% year-on-year, with EBITDA of INR63.5 crores and PAT of INR16.3 crores, which management said were the highest EBITDA and PAT in 18 quarters. The base business grew 24% year-on-year while the commodity Ibuprofen business reported a negative 12% EBITDA margin amid raw material cost pressures linked to the West Asia crisis. Management also reported a reduction in net debt of roughly INR135 crores during the quarter, bringing net debt to approximately INR479 crores.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 53 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.